Summary | BODIPY-FL Nilotinib (Tasigna) for Use in Cancer Research

Crowdsourcing scientists around the world with orphan and dormant intellectual property (IP).

Join Us Sign In

This is the pilot version of Therapoid. Register or Sign in as a pilot user to collaborate.

Provided by: National Institutes of Health (NIH)
Tags: Tyrosine Kinase Inhibitor Tasigna Gastric Cancers CML Nilotinib BODIPY TKI

Short Description:

This technology pertains to bodipy conjugated tyrosine kinase inhibitors that are currently used in the clinic for the treatment of CML or gastric cancers.

Projects based on this Technology

Start New Project